Back

Cause-specific mortality across ICD10 chapters in steatotic liver disease stratified by subtypes and fibrosis status

Feng, Q.; Manousou, P.; Izzi-Engbeaya, C.; Woodward, M.

2025-12-31 epidemiology
10.64898/2025.12.23.25342903 medRxiv
Show abstract

Background and aimsTo examine the associations between Steatotic liver disease (SLD), its subtypes (MASLD, MetALD, ALD), fibrosis stages and mortality from a broad spectrum of diseases. MethodsWe analysed 486156 UK Biobank participants. We summarised the causes of death during follow-up, by SLD status and subtypes. Multivariable Cox models estimated associations between SLD, SLD subtypes, FIB4 score, and cause-specific mortality outcomes across ICD10 disease categories. ResultsAmong 178336 participants with SLD, 20766 died over a median follow up of 13.8 years. The leading causes of deaths were neoplasm (46.4%), circulatory disease (24.2%), respiratory disease (7.0%), and digestive disease (4.8%). Compared to participants without SLD (n=307820), those with SLD had significantly higher mortality from neoplasm (HR 1.24 (1.20, 1.28)), circulatory (1.57 (1.50, 1.64)), and digestive disease (1.85 (1.67, 2.05)), as well as from metabolic, and genitourinary diseases, across all FIB4 score levels. Elevated risks were also observed for mortality from diabetes (3.40 (2.59, 4.46))), Covid-19 (1.97 (1.76, 2.21)), myocardial infarction (1.69 (1.53, 1.86)), stroke (1.24 (1.04, 1.48)), and several cancers, such as breast (1.50 (1.35, 1.68)), colorectal (1.22 (1.11, 1.34)), and prostate cancer (1.22 (1.09, 1.37)). SLD subtypes exhibited distinct patterns of cause-specific mortality. ConclusionSLD is associated with increased mortality across a wide range of disease categories, with extrahepatic cancers and circulatory diseases being the primary contributors. These findings underscore the importance of multidisciplinary management strategies targeting liver fibrosis, cardiometabolic burden, and cancer prevention in individuals with SLD. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=131 SRC="FIGDIR/small/25342903v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1ee89c0org.highwire.dtl.DTLVardef@195a679org.highwire.dtl.DTLVardef@1e45af3org.highwire.dtl.DTLVardef@10f4503_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Journal of Hepatology
21 papers in training set
Top 0.1%
47.9%
2
PLOS ONE
5266 papers in training set
Top 29%
5.4%
50% of probability mass above
3
Communications Medicine
113 papers in training set
Top 0.6%
4.2%
4
eBioMedicine
183 papers in training set
Top 1%
2.6%
5
European Heart Journal
22 papers in training set
Top 0.5%
2.5%
6
Diabetes, Obesity and Metabolism
22 papers in training set
Top 0.4%
2.5%
7
BMC Infectious Diseases
133 papers in training set
Top 2%
2.0%
8
BMC Medicine
176 papers in training set
Top 2%
1.8%
9
Gut
40 papers in training set
Top 0.6%
1.2%
10
Rheumatology
24 papers in training set
Top 0.3%
1.2%
11
Nature Medicine
125 papers in training set
Top 2%
1.2%
12
Scientific Reports
3612 papers in training set
Top 63%
1.2%
13
Nature Communications
5641 papers in training set
Top 50%
1.2%
14
Hepatology
22 papers in training set
Top 0.3%
1.1%
15
Journal of the American Heart Association
140 papers in training set
Top 3%
1.0%
16
The Journal of Clinical Endocrinology & Metabolism
36 papers in training set
Top 0.7%
1.0%
17
eLife
5828 papers in training set
Top 63%
0.9%
18
Metabolism
15 papers in training set
Top 0.4%
0.9%
19
Journal of Cachexia, Sarcopenia and Muscle
33 papers in training set
Top 0.5%
0.9%
20
Hepatology Communications
22 papers in training set
Top 0.3%
0.9%
21
American Journal of Gastroenterology
17 papers in training set
Top 0.3%
0.9%
22
Clinical Infectious Diseases
235 papers in training set
Top 3%
0.6%
23
Gastroenterology
42 papers in training set
Top 1%
0.6%
24
The Lancet Global Health
27 papers in training set
Top 0.7%
0.6%
25
PLOS Genetics
862 papers in training set
Top 13%
0.6%
26
Journal of the American College of Cardiology
12 papers in training set
Top 0.7%
0.6%
27
BMC Public Health
158 papers in training set
Top 5%
0.6%
28
Journal of Translational Medicine
57 papers in training set
Top 2%
0.6%
29
Frontiers in Immunology
638 papers in training set
Top 11%
0.5%
30
BMC Biotechnology
14 papers in training set
Top 0.3%
0.5%